Monopar Therapeutics (MNPR) Change in Accured Expenses (2017 - 2025)
Quarterly results put Change in Accured Expenses at $738682.0 for Q4 2025, down 34.92% from a year ago — trailing twelve months through Dec 2025 was $388218.0 (down 23.4% YoY), and the annual figure for FY2025 was $388218.0, down 23.4%.
Monopar Therapeutics has reported Change in Accured Expenses over the past 9 years, most recently at $738682.0 for Q4 2025.
- Change in Accured Expenses reached $738682.0 in Q4 2025 per MNPR's latest filing, up from $355101.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $1.2 million in Q4 2022 and bottomed at -$770968.0 in Q1 2025.
- Median Change in Accured Expenses over the past 5 years was $13156.5 (2022), compared with a mean of $72187.0.
- The largest annual shift saw Change in Accured Expenses plummeted 10489.49% in 2023 before it skyrocketed 1137.63% in 2025.
- Over 5 years, Change in Accured Expenses stood at $403967.0 in 2021, then skyrocketed by 196.03% to $1.2 million in 2022, then plummeted by 117.81% to -$212999.0 in 2023, then surged by 632.91% to $1.1 million in 2024, then crashed by 34.92% to $738682.0 in 2025.
- Business Quant data shows Change in Accured Expenses for MNPR at $738682.0 in Q4 2025, $355101.0 in Q3 2025, and $65403.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 107.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - | 738,682.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 738,682.00 |
| Dec 31, 2025 | 738,682.00 |
| Sep 30, 2025 | 355,101.00 |
| Sep 30, 2025 | 355,101.00 |
| Jun 30, 2025 | 65,403.00 |
| Jun 30, 2025 | 65,403.00 |
| Mar 31, 2025 | -770,968.00 |
| Mar 31, 2025 | -770,968.00 |
| Dec 31, 2024 | 1.14 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 28,692.00 |
| Sep 30, 2024 | 28,692.00 |
| Jun 30, 2024 | -345,750.00 |
| Jun 30, 2024 | -345,750.00 |
| Mar 31, 2024 | -311,239.00 |
| Mar 31, 2024 | -311,239.00 |
| Dec 31, 2023 | -212,999.00 |
| Dec 31, 2023 | -212,999.00 |
| Sep 30, 2023 | -496,889.00 |
| Sep 30, 2023 | -496,889.00 |
| Jun 30, 2023 | -371,724.00 |
| Jun 30, 2023 | -371,724.00 |
| Mar 31, 2023 | -251,924.00 |
| Mar 31, 2023 | -251,924.00 |
| Dec 31, 2022 | 1.20 Mn |
| Dec 31, 2022 | 1.20 Mn |
| Sep 30, 2022 | -277,524.00 |
| Sep 30, 2022 | -277,524.00 |
| Jun 30, 2022 | 562,338.00 |
| Jun 30, 2022 | 562,338.00 |
| Mar 31, 2022 | -2,379.00 |
| Mar 31, 2022 | -2,379.00 |
| Dec 31, 2021 | 403,967.00 |
| Dec 31, 2021 | 403,967.00 |
| Sep 30, 2021 | 72,942.00 |
| Sep 30, 2021 | 72,942.00 |
| Jun 30, 2021 | 297,452.00 |
| Jun 30, 2021 | 297,452.00 |
| Mar 31, 2021 | -370,394.00 |
| Mar 31, 2021 | -370,394.00 |
| Dec 31, 2020 | 636,970.00 |
| Dec 31, 2020 | 636,970.00 |
| Sep 30, 2020 | -21,418.00 |
| Sep 30, 2020 | -21,418.00 |
| Jun 30, 2020 | 163,152.00 |
| Jun 30, 2020 | 163,152.00 |
| Mar 31, 2020 | -331,106.00 |
| Mar 31, 2020 | -331,106.00 |
| Dec 31, 2019 | 304,229.00 |
| Dec 31, 2019 | 304,229.00 |
| Sep 30, 2019 | -129,416.00 |
| Sep 30, 2019 | -129,416.00 |
| Jun 30, 2019 | -99,131.00 |
| Jun 30, 2019 | -99,131.00 |
| Mar 31, 2019 | 167,852.00 |
| Mar 31, 2019 | 167,852.00 |
| Dec 31, 2018 | 87,658.00 |
| Dec 31, 2018 | 87,658.00 |
| Sep 30, 2018 | -11,248.00 |
| Sep 30, 2018 | -11,248.00 |
| Jun 30, 2018 | 32,544.00 |
| Jun 30, 2018 | 32,544.00 |
| Mar 31, 2018 | -21,270.00 |
| Mar 31, 2018 | -21,270.00 |
| Dec 31, 2017 | -26,070.00 |
| Dec 31, 2017 | -26,070.00 |
| Sep 30, 2017 | 134,849.00 |
| Sep 30, 2017 | 134,849.00 |
| Jun 30, 2017 | 84,719.00 |
| Jun 30, 2017 | 84,719.00 |
| Mar 31, 2017 | 53,859.00 |
| Mar 31, 2017 | 53,859.00 |